The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice

Vaccine

Volumn 31, Issue 41, 2013, Pages 4578-4584

  Zheng, Bin ^a   Lu, Shaohong ^a   Tong, Qunbo ^a   Kong, Qingming ^a   Lou, Di ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Rhoptry protein 5; Subunit vaccines; Th1 Th2; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; RECOMBINANT ANTIGEN; RECOMBINANT RHOPTRY PROTEIN 5; RECOMBINANT SAG1 PROTEIN; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIRULENCE; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL TIME; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

RHOPTRY PROTEIN 5; SUBUNIT VACCINES; TH1/TH2; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL PROLIFERATION; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SURVIVAL ANALYSIS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, SYNTHETIC;

EID: 84883600135     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.058     Document Type: Article

References (49)

1. Black M.W., Boothroyd J.C. Lytic cycle of Toxoplasma gondii. Microbiology and Molecular Biology Reviews 2000, 64(September (3)):607-623.
2. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363(June (9425)):1965-1976.
3. Kravetz J.D., Federman D.G. Toxoplasmosis in pregnancy. American Journal of Medicine 2005, 118(March (3)):212-216.
4. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. International Journal for Parasitology 2000, 30(November (12-13)):1217-1258.
5. Hill D., Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clinical Microbiology and Infection 2002, 8(October (10)):634-640.
6. Kijlstra A., Eissen O.A., Cornelissen J., Munniksma K., Eijck I., Kortbeek T. Toxoplasma gondii infection in animal-friendly pig production systems. Investigative Ophthalmology and Visual Science 2004, 45(September (9)):3165-3169.
7. Kijlstra A., Jongert E. Control of the risk of human toxoplasmosis transmitted by meat. International Journal for Parasitology 2008, 38(October (12)):1359-1370.
8. Kur J., Holec-Gasior L., Hiszczynska-Sawicka E. Current status of toxoplasmosis vaccine development. Expert Review of Vaccines 2009, 8(June (6)):791-808.
9. Innes E.A., Bartley P.M., Maley S., Katzer F., Buxton D. Veterinary vaccines against Toxoplasma gondii. Memorias do Instituto Oswaldo Cruz 2009, 104(March (2)):246-251.
10. Jongert E., Melkebeek V., De Craeye S., Dewit J., Verhelst D., Cox E. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine 2008, 26(February (8)):1025-1031.
11. Boothroyd J.C. Toxoplasma gondii: 25 years and 25 major advances for the field. International Journal for Parasitology 2009, 39(July (8)):935-946.
12. Reichmann G., Dlugonska H., Fischer H.G. Murine Th1 clone defines a 60kD tachyzoite antigen of Toxoplasma gondii. Parasite Immunology 1997, 19(May (5)):229-234.
13. El Hajj H., Demey E., Poncet J., Lebrun M., Wu B., Galeotti N., et al. The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling. Proteomics 2006, 6(November (21)):5773-5784.
14. Reese M.L., Zeiner G.M., Saeij J.P., Boothroyd J.C., Boyle J.P. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(June (23)):9625-9630.
15. Behnke M.S., Khan A., Wootton J.C., Dubey J.P., Tang K., Sibley L.D. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(June (23)):9631-9636.
16. Martens S., Parvanova I., Zerrahn J., Griffiths G., Schell G., Reichmann G., et al. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathogens 2005, 1(November (3)):e24.
17. Khaminets A., Hunn J.P., Konen-Waisman S., Zhao Y.O., Preukschat D., Coers J., et al. Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cellular Microbiology 2010, 12(July (7)):939-961.
18. Fleckenstein M.C., Reese M.L., Konen-Waisman S., Boothroyd J.C., Howard J.C., Steinfeldt T. A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins. PLoS Biology 2012, 10(7):e1001358.
19. Reese M.L., Boothroyd J.C. A conserved non-canonical motif in the pseudoactive site of the ROP5 pseudokinase domain mediates its effect on Toxoplasma virulence. Journal of Biological Chemistry 2011, 286(August (33)):29366-29375.
20. Niedelman W., Gold D.A., Rosowski E.E., Sprokholt J.K., Lim D., Farid Arenas A., et al. The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathogens 2012, 8(6):e1002784.
21. Letscher-Bru V., Pfaff A.W., Abou-Bacar A., Filisetti D., Antoni E., Villard O., et al. Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infection and Immunity 2003, 71(November (11)):6615-6619.
22. Liu Q., Shang L., Jin H., Wei F., Zhu X.Q., Gao H. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18. Research in Veterinary Science 2010, 89(August (1)):93-97.
23. Zhang G., Huang X., Boldbaatar D., Battur B., Battsetseg B., Zhang H., et al. Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice. Vaccine 2010, 28(October (45)):7243-7247.
24. Dziadek B., Gatkowska J., Grzybowski M., Dziadek J., Dzitko K., Dlugonska H. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice. Experimental Parasitology 2012, 131(May (1)):133-138.
25. Hoseinian Khosroshahi K., Ghaffarifar F., D'Souza S., Sharifi Z., Dalimi A. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis. Vaccine 2011, 29(January (4)):778-783.
26. Machado A.V., Caetano B.C., Barbosa R.P., Salgado A.P., Rabelo R.H., Garcia C.C., et al. Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity. Vaccine 2010, 28(April (18)):3247-3256.
27. Cong H., Zhang M., Xin Q., Wang Z., Li Y., Zhao Q., et al. Compound DNA vaccine encoding SAG1/SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii. Parasit Vectors 2013, 6:63.
28. Wu X.N., Lin J., Lin X., Chen J., Chen Z.L., Lin J.Y. Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice. Parasitology Research 2012, 111(November (5)):2001-2009.
29. Hiszczynska-Sawicka E., Oledzka G., Holec-Gasior L., Li H., Xu J.B., Sedcole R., et al. Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii. Veterinary Parasitology 2011, 177(May (3-4)):281-289.
30. Xue M., He S., Cui Y., Yao Y., Wang H. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Parasitology International 2008, 57(December (4)):424-429.
31. Sanchez V.R., Pitkowski M.N., Fernandez Cuppari A.V., Rodriguez F.M., Fenoy I.M., Frank F.M., et al. Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection. Experimental Parasitology 2011, 128(August (4)):448-453.
32. Sun X.M., Zou J.A.A.E., Yan W.C., Liu X.Y., Suo X., et al. DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice. Parasites & Vectors 2011, 4:213.
33. Li W.S., Chen Q.X., Ye J.X., Xie Z.X., Chen J., Zhang L.F. Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses. Parasitology Research 2011, 109(September (3)):637-644.
34. Yuan Z.G., Zhang X.X., He X.H., Petersen E., Zhou D.H., He Y., et al. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clinical and Vaccine Immunology 2011, 18(January (1)):119-124.
35. Qu D., Han J., Du A. Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice. Parasitology Research 2013, 112:2593-2599.
36. Yuan Z.G., Zhang X.X., Lin R.Q., Petersen E., He S., Yu M., et al. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 2011, 29(September (38)):6614-6619.
37. Hiszczynska-Sawicka E., Li H., Boyu Xu J., Akhtar M., Holec-Gasior L., Kur J., et al. Induction of immune responses in sheep by vaccination with liposome-entrapped DNA complexes encoding Toxoplasma gondii MIC3 gene. Polish Journal of Veterinary Sciences 2012, 15(1):3-9.
38. Fang R., Feng H., Hu M., Khan M.K., Wang L., Zhou Y., et al. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii. Veterinary Parasitology 2012, 187(June (1-2)):140-146.
39. Peng G.H., Yuan Z.G., Zhou D.H., He X.H., Liu M.M., Yan C., et al. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine 2009, 27(November (47)):6570-6574.
40. Liu Q., Gao S., Jiang L., Shang L., Men J., Wang Z., et al. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microbes and Infection 2008, 10(October (12-13)):1355-1362.
41. Qu D., Yu H., Wang S., Cai W., Du A. Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Veterinary Parasitology 2009, 166(December (3-4)):220-227.
42. Roland K., Curtiss R., Sizemore D. Construction and evaluation of a delta cya delta crp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Diseases 1999, 43(July-September (3)):429-441.
43. Sayles P.C., Gibson G.W., Johnson L.L. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infection and Immunity 2000, 68(March (3)):1026-1033.
44. Siachoque H., Guzman F., Burgos J., Patarroyo M.E., Gomez Marin J.E. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Experimental Parasitology 2006, 114(September (1)):62-65.
45. Letscher-Bru V., Villard O., Risse B., Zauke M., Klein J.P., Kien T.T. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infection and Immunity 1998, 66(September (9)):4503-4506.
46. Bonenfant C., Dimier-Poisson I., Velge-Roussel F., Buzoni-Gatel D., Del Giudice G., Rappuoli R., et al. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infection and Immunity 2001, 69(March (3)):1605-1612.
47. LaRosa D.F., Stumhofer J.S., Gelman A.E., Rahman A.H., Taylor D.K., Hunter C.A., et al. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(March (10)):3855-3860.
48. Qu D.F., Yu H.J., Liu Z., Zhang D.F., Zhou Q.J., Zhang H.L., et al. Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen. Veterinary Parasitology 2011, 179(June (1-3)):28-34.
49. Dziadek B., Gatkowska J., Brzostek A., Dziadek J., Dzitko K., Dlugonska H. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Experimental Parasitology 2009, 123(September (1)):81-89.